Pierre Fabre S.A. Archives - LevinPro Healthcare M&A

Vision Innovation Partners Expands in Maryland

by Kate Humphrey | Mar 31, 2026 1:41 pm | Physician Medical Groups
Vision Innovation Partners (VIP) has expanded its Maryland presence with the acquisition of Frederick Eye Institute. Frederick Eye Institute, based in Frederick, Maryland, is a comprehensive ophthalmology practice. It specializes in cataract surgery and lens implants. The practice also employs the latest technology to provide care... Read More »
Citizens Advises Lync Health Partners on its Majority Recapitalization

by Avery Swett | Mar 31, 2026 12:28 pm | Outpatient Surgery Center
Citizens Capital Markets & Advisory has served as exclusive financial advisor to Lync Health Partners on its majority recapitalization by United Surgical Partners International. Citizens Capital Markets & Advisory is part of the institutional broker-dealer, Citizens JMP Securities, LLC, a subsidiary of Citizens Financial Group. Lync... Read More »
Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

by Avery Swett | Mar 31, 2026 12:26 pm | Biotechnology
Eli Lilly and Company announced on March 31 that it will be acquiring Boston- and London-based Centessa Pharmaceuticals. Centessa Pharmaceuticals is a clinical-stage pharmaceutical company developing a new class of drugs for the treatment of excessive daytime sleepiness and other neurological conditions. Centessa’s lead program... Read More »
Sidelined Capital: A Healthcare Webinar Wrap Up

by Kate Humphrey | Mar 31, 2026 9:57 am | Healthcare M&A News Leads
Earlier in March, Ben Swett, Managing Editor of The SeniorCare Investor, was joined by John Tiedmann, Managing Director at Physician Growth Partners, Bill Hoffman, Shareholder at Polsinelli and Matt Bogle, Managing Director at Intrinsic, to examine key factors fueling and impeding healthcare services M&A deal volume. In a follow-up to... Read More »
A New Normal? Q1:26 Healthcare M&A Stalls

by Dylan Sammut | Mar 31, 2026 9:40 am | Healthcare Market Updates
According to data captured in our LevinPro HC platform, healthcare M&A stalled in the first quarter of 2026, reaching only 527 deals, a modest 3% dip compared with the fourth quarter. The difference in volume is small enough to feel almost arbitrary, but these slight quarter-over-quarter variations have become the norm over the past 24... Read More »

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40

Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121

Small World: The Week of International Pharma Deals

by Dylan Sammut | Apr 8, 2019 12:28 pm | Pharmaceuticals

Last week, the list of pharmaceutical deals announced also could have served as a geography lesson. Not only was the volume of deals particularly high, accounting for nearly 28% of the week’s total, but it had a diverse list of countries. Beginning in the United States, New York City-based Royalty Pharma, which focuses entirely on acquiring royalty interests in marketed and late-stage biopharmaceutical products, acquired the royalty interest in Indianapolis-based Eli Lilly’s (NYSE: LLY) Emgality from Arteaus Therapeutics (Cambridge, Massachusetts) for $260 million. Advanz Pharma Corp. (ADVZ.TO), a Canadian pharmaceutical company, bought the global rights to two drugs for $33.3... Read More »

Vision Innovation Partners Expands in Maryland

Citizens Advises Lync Health Partners on its Majority Recapitalization

Eli Lilly to Acquire Centessa Pharmaceuticals for $6.3 Billion

Sidelined Capital: A Healthcare Webinar Wrap Up

A New Normal? Q1:26 Healthcare M&A Stalls

Small World: The Week of International Pharma Deals

Schedule a demo

Categories

Archives

Irving Levin Associates LLC